Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL711971

O=C(O)C(F)(F)F.c1ccc(COc2ccc(-c3nc4cccnc4[nH]3)c(OCc3ccccc3)c2)cc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
PDE5A O76074 1/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
CYP11B1 P15538 3/20 0.41
CYP11B2 P19099 3/20 0.41
CHEK2 O96017 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
SRD5A2 P31213 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
PDK2 Q15119 1/20 0.39
PPIA P62937 2/20 0.39
CCNT1 O60563 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL709199 0.95 PTPN1 (0.43) CYP3A4PDE5APDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL711226 0.93 SMO (0.41) CYP3A4PDE5APDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL709554 0.92 CYP3A4 (0.43) CYP3A4PDE5APDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL713321 0.92 FFAR1 (0.41) CYP3A4PDE5APDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL711286 0.91 PDE5A (0.41) CYP3A4PDE5APDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL711950 0.91 CYP3A4 (0.39) CYP3A4PDE5APDE4APDE4BPDE4C
SCHEMBL9071887 0.91 CYP3A4 (0.51) CYP3A4PDE5APDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL712956 0.88 GPR132 (0.45) LRRK2
Trifluoroacetic Acid SCHEMBL711595 0.87 LRRK2 (0.43) CYP3A4PDE5APDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL713332 0.87 KMT2A (0.41) CYP3A4PDE5APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK CYP3A4 193/4885PDE5A 593/4885PDE4A 502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.